Assay could direct treatment options for triple-negative breast cancer. Accumulations of telomere AI predicted sensitivity to therapy. PHILADELPHIA — Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum...
Filed under: Press Releases, Research, Treatment, Breast Cancer, Cancer, Media Materials, AACR, American Association for Cancer Research, Cancer Discovery, chemotherapy, women, journal, triple-negative breast cancer, tAI, telomeric allelic imbalance, platinum chemotherapy, cisplatin, carboplatin, Dr. Andrea Richardson